Summary
The product Femavar 2.5, manufactured by Pharmago Labs, underwent independent testing to verify its authenticity and potency. The sample, submitted by the Manufacturer Pharmaqo Labs mrp@vitamins.to, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Oxandrolone, with a concentration of 2.36 mg, slightly below the labeled claim of 2.5 mg by 5.6%.
The testing process began on 1 February 2024, with the analysis completed on the same day. While the results confirm the presence of Oxandrolone, the batch number was not provided, and the sample description lacked detailed information. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Pharmaqo Labs
- Product Name: Femavar 2.5
- Active Ingredient: Oxandrolone
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #38192
- Testing Ordered: 1 February 2024
- Sample Received: 1 February 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Pharmaqo Labs (Manufacturer)
- Analysis Paid For By: Pharmaqo Labs (Manufacturer)
Testing Results
- Specification: 2.5 mg (as stated on the label)
- Measured Concentration: 2.36 mg
- Accuracy: 94.4% (5.6% below the label claim)
- Variance: 5.6
Verification Details
- Verification URL: https://janoshik.com/tests/38192_2UGEKY28HFJQ
Evaluation of Manufacturer-Submitted Testing
This analysis highlights the presence of Oxandrolone in the tested sample but warrants careful evaluation due to the lack of detailed sample information and batch number. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results.
Conclusion
The analysis confirms that Femavar 2.5 is slightly underdosed, with a measured concentration of 2.36 mg. This result reflects the need for additional testing and detailed sample information to ensure product consistency and reliability. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
